Global Diabetes Prevalence and Future Projections
Currently, there are approximately 537 million people (10.5% of the global population) living with diabetes worldwide, and this number is projected to reach 783 million by 2045, representing a 46% increase over the next two decades. 1
Current Global Diabetes Statistics (2021-2023)
- The worldwide prevalence of diabetes in adults aged 20-79 years was estimated at 537 million people (10.5% of all adults in this age range) in 2021 1, 2
- Approximately 45% of people with diabetes worldwide remain undiagnosed 1
- Type 2 diabetes accounts for 96.0% of all diabetes cases and 95.4% of diabetes-related disability-adjusted life years (DALYs) globally 3
- About 6.7 million adults worldwide died from diabetes-related causes in 2021 1
- Global healthcare expenditure on diabetes was approximately $966 billion in 2021 1
Regional Distribution
- North Africa and the Middle East have the highest age-standardized diabetes prevalence at 9.3% 3
- At the regional level, Oceania has the highest prevalence at 12.3% 3
- China and India have the largest number of people with diabetes:
- In the United States, 37.3 million people (11.3% of the population) have diabetes 1
Future Projections
By 2030, global diabetes prevalence is expected to reach 643 million people 2, 3
By 2045, projections indicate:
By 2050, more alarming projections show:
Risk Factors and Contributors
- High body mass index (BMI) is responsible for 52.2% of global type 2 diabetes DALYs 3
- The contribution of high BMI to type 2 diabetes DALYs rose by 24.3% worldwide between 1990 and 2021 3
- Prediabetes affects an estimated 352.1 million people worldwide, with projections reaching 531.6 million by 2045 4
- Diabetes disproportionately affects low and middle-income countries, which account for 77% of all people with diabetes worldwide 4
Health and Economic Impact
- Diabetes is the fourth most common cause of death in the developed world 1
- The annual per capita healthcare costs for individuals with diabetes are approximately 2.3-fold higher than for those without diabetes 1
- In the United States, the cost of diabetes increased from $245 billion in 2012 to $327 billion by 2017 1
Clinical Implications
- The increasing prevalence of diabetes will significantly impact healthcare systems globally, requiring enhanced prevention strategies and treatment resources 3
- Early identification and management of type 2 diabetes is crucial, as it is largely preventable and potentially reversible in some cases if identified early 3
- Understanding population-specific risk factor profiles is essential for developing targeted prevention and control strategies 3